Roche Diagnostics Operations, Inc.

Roche Diagnostics Gmbh

F. Hoffmann-la Roche Ag

Gabriele Pestlin

Christoph Seidel

Johann Karl

Herbert Andres

Thomas Meier

Rainer Schmuck

Wilhelm Tischer

Eva Hoess

Klaus Reichert

Marie-Luise Hagmann

Peter Berndt

Werner Zolg

Bernd Schneidinger

Hanno Langen

Ursula Kunert

Friedrich Popp

The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein ASC (apoptosis-associated speck-like protein containing a caspase-associated recruitment domain) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring ASC in said sample. Measurement of ASC can, e.g., be used in the early detection or diagnosis of colorectal cancer.

ASC as a marker for colorectal cancer

The present invention relates to the diagnosis of breast cancer. It discloses the use of protein cellular retinoic acid binding protein II in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring cellular retinoic acid binding protein II in said sample. Measurement of cellular retinoic acid binding protein II can, e.g., be used in the early detection or diagnosis of breast cancer.

Cellular retinoic acid binding protein II as a marker for breast cancer

The present invention relates to the diagnosis of breast cancer. It discloses the use of protein ASC in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring ASC in the sample. Measurement of ASC can, e.g., be used in the early detection or diagnosis of breast cancer.

Use of protein ASC as a marker for breast cancer

Growing community of inventors

Munich, Germany

Gabriele Pestlin